Agios Pharmaceuticals, Inc.
AGIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001439222
In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Agios Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 161 | 4 | 157 | 0 |
| Shares | 59.9M | 54.1K | 58.9M | −899.0K (−1.5%) |
| Value | $1.74B | $1.58M | $1.31B | −$433.3M (−24.9%) |
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Federated Hermes, Inc. | 377,160 | $8.36M | 0.02% |
| Bank of Montreal | 174,999 | $4.00M | 0.00% |
| Parallax Volatility Advisers, L.P. | 137,231 | $3.04M | 0.01% |
| Graham Capital Management, L.P. | 110,585 | $2.45M | 0.11% |
| Assenagon Asset Management S.A. | 109,302 | $2.42M | 0.01% |
| Thrivent Financial for Lutherans | 103,319 | $2.29M | 0.01% |
| Man Group plc | – | $1.69M | 0.01% |
| Renaissance Technologies LLC | 62,000 | $1.38M | 0.00% |
| Marshall Wace, LLP | 43,563 | $966.0K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 23,422 | $519.0K | 0.00% |
| Caxton Associates LP | 21,228 | $471.0K | 0.06% |
| DekaBank Deutsche Girozentrale | 20,000 | $439.0K | 0.00% |
| Campbell & CO Investment Adviser LLC | 16,564 | $367.0K | 0.10% |
| Cubist Systematic Strategies, LLC | 10,787 | $239.0K | 0.00% |
| Simplex Trading, LLC | 9,810 | $217.0K | 0.01% |
| SEI Investments Co | 9,716 | $213.0K | 0.00% |
| Point72 Hong Kong Ltd | 1,745 | $39.0K | 0.00% |
| Gladius Capital Management LP | 758 | $17.0K | 0.00% |
| Bell Investment Advisors, Inc | 188 | $4.00K | 0.00% |
| Steward Financial Group LLC | 5 | $0 | 0.00% |
Sold out (20)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| State of New Jersey Common Pension Fund D | 87,567 | $2.55M |
| Susquehanna International Group, LLP | 52,659 | $1.53M |
| Alaska Permanent Fund Corp | 44,700 | $1.30M |
| Edgewood Management LLC | 20,000 | $582.0K |
| Caption Management, LLC | 19,000 | $552.0K |
| Nomura Holdings Inc | 13,000 | $391.0K |
| Handelsbanken Fonder AB | 11,723 | $341.0K |
| Walleye Trading LLC | 11,522 | $335.0K |
| Teacher Retirement System of Texas | 10,068 | $293.0K |
| Connacht Asset Management LP | 9,648 | $281.0K |
| Janus Henderson Group PLC | 8,584 | $250.0K |
| Profund Advisors LLC | 8,372 | $244.0K |
| Jump Financial, LLC | 8,300 | $242.0K |
| Quantbot Technologies LP | 1,202 | $34.0K |
| TCI Wealth Advisors, Inc. | 193 | $6.00K |
| Aquatic Capital Management LLC | 200 | $6.00K |
| Prospera Financial Services Inc | 75 | $2.00K |
| Dark Forest Capital Management LP | 43 | $1.00K |
| Ellevest, Inc. | 7 | $0 |
| Cordant, Inc. | 5 | $0 |
Not filed for Q2 2022 yet (4)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 26,864 | $782.0K |
| Virginia Retirement Systems Et Al | 20,700 | $603.0K |
| Amalgamated Financial Corp. | 6,556 | $191.0K |
| SJS Investment Consulting Inc. | 1 | $0 |